We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Urology

Journal Scan / Research · May 24, 2017

Long-Term Outcomes After Bladder-Preserving Trimodal Therapy for Patients With Muscle-Invasive Bladder Cancer

European Urology


Additional Info

Disclosure statements are available on the authors' profiles:

European Urology
Long-Term Outcomes After Bladder-Preserving Tri-Modality Therapy for Patients With Muscle-Invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
Eur Urol 2017 Jun 01;71(6)952-960, NJ Giacalone, WU Shipley, RH Clayman, A Niemierko, M Drumm, NM Heney, MD Michaelson, RJ Lee, PJ Saylor, MF Wszolek, AS Feldman, DM Dahl, AL Zietman, JA Efstathiou

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading